普生股份有限公司
成立於1984年6月，擁有研究、開發、製造、銷售到檢驗服務之完整供應鏈體系，逾三十年來，普生的目標始終如一，即創造每個人都能使用的更好、更實惠的體外診斷產品(IVD)，產品組合包括傳染病、呼吸道感染、血液病毒學、生育相關和性健康、腫瘤學和人類遺傳學以及新出現的傳染病等，且旗下體外診斷產品和設備現已成為全球醫院專業人員、實驗室技術人員、血庫和消費者值得信賴的解決方案，銷售至全球40多國。 普生戮力從檢測領域出發，致力於結合檢測與其他治療方式，朝向精準、預防、生活大健康領域發展，業務涵蓋精準體外診斷試劑(IVD)、數位醫療診斷服務(DML)、抗菌胜肽(AMP)藥品及保健產品商轉化等，以多元化業務模式建構朝向大健康領域長期發展。
For more than 30 years, our purpose has remained the same — to create better and more affordable in-vitro diagnostics that are accessible to everyone. Our in-vitro diagnostic tests portfolio including respiratory infections, blood virology, women’s and sexual health, oncology and human genetics and emerging infectious diseases, and equipment are now the trusted solution for hospital professionals, lab technicians, blood banks, and consumers worldwide.
The company has also entered the consumable products market with their brand ‘oh care’ — a range of oral care products for infants and adults that uses the P113 patented peptide raw material.
會員登入
註冊
